These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23106334)

  • 1. Rapid and complete reconstitution of autologous haemopoiesis after cord blood infusion in treatment-naive patients with severe aplastic anemia receiving high-dose cyclophosphamide/ATG therapy.
    Li Y; Sheng Z; Niu S; Ge L; Ren C; Zou Y
    Eur J Haematol; 2013 Jan; 90(1):45-50. PubMed ID: 23106334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased immunosuppressive treatment combined with unrelated umbilical cord blood infusion in children with severe aplastic anemia.
    Xie LN; Fang Y; Yu Z; Song NX; Kong FS; Liu XM; Zhou F
    Cell Immunol; 2014; 289(1-2):150-4. PubMed ID: 24838091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fludarabine, cyclophosphamide and horse antithymocyte globulin conditioning regimen for allogeneic peripheral blood stem cell transplantation performed in non-HEPA filter rooms for multiply transfused patients with severe aplastic anemia.
    Kumar R; Prem S; Mahapatra M; Seth T; Chowdhary DR; Mishra P; Pillai L; Narendra AM; Mehra NK; Saxena R; Choudhry VP
    Bone Marrow Transplant; 2006 Apr; 37(8):745-9. PubMed ID: 16518427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose cyclophosphamide compared with antithymocyte globulin for treatment of acquired severe aplastic anemia.
    Zhang F; Zhang L; Jing L; Zhou K; Wang H; Peng G; Li Y; Li Y; Li J; Ye L; Shi L; Fan H; Zhao X; Chu Y; Hao Y; Wang J
    Exp Hematol; 2013 Apr; 41(4):328-34. PubMed ID: 23313080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial.
    Tisdale JF; Dunn DE; Geller N; Plante M; Nunez O; Dunbar CE; Barrett AJ; Walsh TJ; Rosenfeld SJ; Young NS
    Lancet; 2000 Nov; 356(9241):1554-9. PubMed ID: 11075769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects and Predictive Factors of Immunosuppressive Therapy Combined with Umbilical Cord Blood Infusion in Patients with Severe Aplastic Anemia.
    Zhang X; Li Z; Geng W; Song B; Wan C
    Yonsei Med J; 2018 Jul; 59(5):643-651. PubMed ID: 29869462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cord blood infusion-accelerated hematopoietic recovery after combined immunosuppressive therapy with fludarabine and rabbit ATG in severe aplastic anemia.
    Jiang J; Cai Y; Wan L; Yang J; Wang C
    Int J Hematol; 2020 Mar; 111(3):360-368. PubMed ID: 31900878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bone marrow transplantation for severe aplastic anemia].
    Bullorsky EO; Bonduel M; Shanley C; Figueroa C; Stemmelin G; Del Pozo A; Ceresetto J; Delfino S; Puppo M; Muriel FS
    Medicina (B Aires); 1998; 58(2):130-4. PubMed ID: 9706244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized comparison of cyclophosphamide vs. reduced dose cyclophosphamide plus fludarabine for allogeneic hematopoietic cell transplantation in patients with aplastic anemia and hypoplastic myelodysplastic syndrome.
    Kim H; Lee JH; Joo YD; Bae SH; Hyun MS; Lee JH; Kim DY; Lee WS; Ryoo HM; Kim MK; Park JH; Lee KH;
    Ann Hematol; 2012 Sep; 91(9):1459-69. PubMed ID: 22526363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia.
    Brodsky RA; Sensenbrenner LL; Smith BD; Dorr D; Seaman PJ; Lee SM; Karp JE; Brodsky I; Jones RJ
    Ann Intern Med; 2001 Oct; 135(7):477-83. PubMed ID: 11578150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemia.
    McGuinn C; Geyer MB; Jin Z; Garvin JH; Satwani P; Bradley MB; Bhatia M; George D; Duffy D; Morris E; van de Ven C; Schwartz J; Baxter-Lowe LA; Cairo MS
    Pediatr Blood Cancer; 2014 Jul; 61(7):1289-94. PubMed ID: 24623601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia.
    Kang HJ; Shin HY; Choi HS; Ahn HS
    Bone Marrow Transplant; 2004 Dec; 34(11):939-43. PubMed ID: 15489866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin.
    Kröger N; Zabelina T; Renges H; Krüger W; Kordes U; Rischewski J; Schrum J; Horstmann M; Ayuk F; Erttmann R; Kabisch H; Zander AR
    Ann Hematol; 2002 Nov; 81(11):627-31. PubMed ID: 12454700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study.
    Shin SH; Yoon JH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Park CW; Lee JW
    Ann Hematol; 2013 Jun; 92(6):817-24. PubMed ID: 23318980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Unrelated bone marrow transplantation in two severe aplastic anemia patients preconditioned with a regimen of cyclophosphamide, antithymocyte globulin, and total body irradiation].
    Mizue N; Watanabe J; Katoh S; Oda T; Suzuki N; Kudoh T
    Rinsho Ketsueki; 1999 Mar; 40(3):213-7. PubMed ID: 10222628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Umbilical cord blood transplant for adult patients with severe aplastic anemia using anti-lymphocyte globulin and cyclophosphamide as conditioning therapy.
    Mao P; Wang S; Wang S; Zhu Z; Liv Q; Xuv Y; Mo W; Ying Y
    Bone Marrow Transplant; 2004 Jan; 33(1):33-8. PubMed ID: 14704655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced dose cyclophosphamide, fludarabine and antithymocyte globulin for sibling and unrelated transplant of children with severe and very severe aplastic anemia.
    Chung NG; Lee JW; Jang PS; Jeong DC; Cho B; Kim HK
    Pediatr Transplant; 2013 Jun; 17(4):387-93. PubMed ID: 23551397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rabbit antithymocyte globulin treatment in childhood acquired severe aplastic anemia.
    Karapinar DY; Karadaş N; Ay Y; Akin M; Balkan C; Aydinok Y; Kavakli K
    Pediatr Hematol Oncol; 2014 Feb; 31(1):20-8. PubMed ID: 23627541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Saudi experience in fludarabine-based conditioning regimens in patients with Fanconi anemia undergoing stem cell transplantation: excellent outcome in recipients of matched related stem cells but not in recipients of unrelated cord blood stem cells.
    Ayas M; Al-Seraihi A; El-Solh H; Al-Ahmari A; Khairy A; Aldali A; Markiz S; Siddiqui K; Al-Jefri A
    Biol Blood Marrow Transplant; 2012 Apr; 18(4):627-32. PubMed ID: 21871862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophosphamide and antithymocyte globulin conditioning may be sufficient for Korean patients with early stage severe aplastic anemia transplanted with marrow from donors other than HLA-identical siblings.
    Lee JH; Lee JH; Lee JS; Kim WK; Chi HS; Lee KH
    Haematologica; 2001 Apr; 86(4):434-5. PubMed ID: 11325653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.